Search results
Results from the WOW.Com Content Network
The Philippines is a low-HIV-prevalence country, with 0.1 percent of the adult population estimated to be HIV-positive, but the rate of increase in infections is one of the highest. [7] As of August 2019, the Department of Health (DOH) AIDS Registry in the Philippines reported 69,629 cumulative cases since 1984. [ 8 ]
This page was last edited on 30 October 2020, at 07:14 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
HIV Mylan: NNRTI 1998 Elvitegravir: HIV Gilead Sciences Integrase inhibitor 2012 (Fixed-dose combo Stribild) 2014 (single pill) 2015 ; Emtricitabine: HIV Gilead Sciences NRTI 2003 Enfuvirtide: HIV Entry inhibitor 2003 Ensitrelvir: COVID-19: Shionogi: 3C-like protease inhibitor Entecavir: HIV NRTI 2005 Etravirine (Intelence) [8] HIV NNRTI 2008 ...
Various approaches for HIV vaccine development. As of 2020, no effective vaccine for HIV or AIDS is known. [61] A single trial of the vaccine RV 144 found a partial efficacy rate around 30% and has stimulated optimism in the research community regarding developing a truly effective vaccine. [62] Further trials of the vaccine are ongoing. [63] [64]
In 2008, 4.7 million people in Asia were living with human immunodeficiency virus (HIV). Asia's epidemic peaked in the mid-1990s, and annual HIV incidence has declined since then by more than half. Regionally, the epidemic has remained somewhat stable since 2000. [1] People living with HIV/AIDS , in absolute numbers for the year of 2008. Large ...
The IATF-EID convened in January 2020 to address the growing viral outbreak in Wuhan, China. [5] They made a resolution to manage the spreading of the new virus, [5] which was known at the time as 2019 novel coronavirus (2019-nCoV) and eventually renamed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. [6]
An HIV vaccine is a potential vaccine that could be either a preventive vaccine or a therapeutic vaccine, which means it would either protect individuals from being infected with HIV or treat HIV-infected individuals. It is thought that an HIV vaccine could either induce an immune response against HIV (active vaccination approach) or consist of ...
An HIV vaccine is a vaccine that would be given to a person who does not have HIV, in order to confer protection against subsequent exposures to HIV, thus reducing the likelihood that the person would become infected by HIV. Currently, no effective HIV vaccine exists. Various HIV vaccines have been tested in clinical trials almost since the ...